Adaptive Biotechnologies to Report Second Quarter of 2022 Financial Results on August 3, 2022
09 July 2022 - 6:05AM
Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a
commercial-stage biotechnology company that aims to translate the
genetics of the adaptive immune system into clinical products to
diagnose and treat disease, today announced it will report
financial results for the second quarter 2022 after market close on
Wednesday, August 3, 2022. Company management will webcast a
corresponding conference call beginning at 1:30 p.m. Pacific Time /
4:30 p.m. Eastern Time.
To attend the conference call or webcast, participants should
register online. Participants are requested to register a day in
advance or at a minimum 15 minutes before the start of the call.
The webcast will be archived and available for replay within 24
hours after the event on the “Investors” section of the company
website at: www.adaptivebiotech.com.
About Adaptive BiotechnologiesAdaptive
Biotechnologies is a commercial-stage biotechnology company
focused on harnessing the inherent biology of the adaptive immune
system to transform the diagnosis and treatment of disease. We
believe the adaptive immune system is nature’s most finely tuned
diagnostic and therapeutic for most diseases, but the inability to
decode it has prevented the medical community from fully leveraging
its capabilities. Our proprietary immune medicine platform reveals
and translates the massive genetics of the adaptive immune system
with scale, precision and speed to develop products in our Immune
Medicine and Minimal Residual Disease (MRD) businesses. We have
three commercial products and a robust clinical pipeline to
diagnose, monitor and enable the treatment of diseases such as
cancer, autoimmune conditions and infectious diseases. For more
information, please visit adaptivebiotech.com and follow us
on www.twitter.com/adaptivebiotech.
ADAPTIVE INVESTORSKarina Calzadilla, Vice
President, Investor Relations201-396-1687Carrie
Mendivil, Gilmartin
Groupinvestors@adaptivebiotech.com
ADAPTIVE MEDIALaura
Cooper206-693-2042media@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Apr 2023 to Apr 2024